| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/20/2000 | CN1267215A Pharmacetical compositions contg. effervescent acid-base couple |
| 09/20/2000 | CN1267214A Novel formulations of pharmacological agents, method for preparation thereof and method for use thereof |
| 09/20/2000 | CN1267191A Composition and method for treating penile erectile dysfunction |
| 09/20/2000 | CN1266850A O-substd. hydroxy coumaranone derivs as antineoplastic and antitransfer agent |
| 09/20/2000 | CN1266699A Anti-infectious antipyretic and antalgic medicine |
| 09/20/2000 | CN1266689A Gel for treating tooth anaphylactia and occulation facing |
| 09/20/2000 | CN1266687A Application of Sichuan champion bauhinia saponin in preparing anti-tumor medicine |
| 09/20/2000 | CN1266686A Medicinal composition for treating diabetes |
| 09/20/2000 | CN1266685A Process for preparing long-acting compound analgesic |
| 09/20/2000 | CN1266684A Compound preparation for treating coccidiosis |
| 09/20/2000 | CN1266683A Medicinal composition containing dihydroartemisine for treating rosacea and photosensitive diseases |
| 09/20/2000 | CN1266682A Quick-acting aerosol for treating stenocardia and preparing process thereof |
| 09/20/2000 | CN1266681A Carbocisteine composition for promoting healing of wound and burn |
| 09/20/2000 | CN1266680A Application of ursolic acid in medicine for treating viral hepatitis |
| 09/20/2000 | CN1056617C Melanoma-inhibiting protein |
| 09/20/2000 | CN1056611C Pyrazolo and pyrrolopyridines, their use and intermidiates for preparing same |
| 09/20/2000 | CN1056610C Piperidine or piperazine derivs, pharmaceutical compositions contg. them and their use |
| 09/20/2000 | CN1056609C Benzoyl guanidines, their production and their use in medicinal compositions |
| 09/20/2000 | CN1056608C Pseudodipeptide product having imidazole group and applications |
| 09/20/2000 | CN1056607C Tricyclic pyrazole derivs. |
| 09/20/2000 | CN1056606C Substd. dihydro-pyridine dicarboxylate, its preparing method, medicine contg. same and use thereof |
| 09/20/2000 | CN1056605C Compounds as selective human NK 3-receptor antagonists and their use |
| 09/20/2000 | CN1056602C Esters and amides as PLAZ inhibitors |
| 09/20/2000 | CN1056599C Bis (phenyl) ethane derivs. |
| 09/20/2000 | CN1056524C Plaster for treating burn and scald and its preparation method |
| 09/20/2000 | CN1056514C Quick blood-forming agent |
| 09/20/2000 | CN1056512C Medicine for treatment of trigeminal neuralgia |
| 09/20/2000 | CN1056511C Process for preparing composition for beauty or pharmaceutical, especially dermotoses and antiallergy by using cucurbin, and use |
| 09/20/2000 | CN1056510C Method for increasing galactopoiesis power of female bovidae |
| 09/19/2000 | US6121479 Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics |
| 09/19/2000 | US6121469 Stimulant of mitogen-activated protein kinase; bone, autoimmune, kidney, liver, and skin disorders |
| 09/19/2000 | US6121461 Form III crystalline [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl )-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1) |
| 09/19/2000 | US6121459 Reacting aryl-substituted-propargylhydroxylamine with azabicycloketone; oximination |
| 09/19/2000 | US6121451 Anticancer drugs |
| 09/19/2000 | US6121449 Testosterone 5 alpha-reductase inhibitory activity; useful in therapy in the treatment of hyperandrogenic conditions |
| 09/19/2000 | US6121434 An oligonucleotide diagnostic agent; for the diagnosis and treatment of cancer, restenosis, a nd viral diseases affected by intergrins |
| 09/19/2000 | US6121431 Nucleoside derivatives |
| 09/19/2000 | US6121416 Peptide which prevents the binding of somatomedins and their binding proteins; for the treatment of hyperglycemic, obesity, nervous system, cardiovascular, kidney, immunological and metabolic disorders |
| 09/19/2000 | US6121414 Protein which can be used to screen for antibiotic activity; for prevention of bacterial infections; bactericides |
| 09/19/2000 | US6121375 Gels formed by the interaction of poly(aldehyde) with various substances |
| 09/19/2000 | US6121343 Perfume-containing controlled release biodegradable resin composition |
| 09/19/2000 | US6121330 Cardiovascular disorders; anticholesterol agents; antilipemic agents |
| 09/19/2000 | US6121329 Topical administration of 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol |
| 09/19/2000 | US6121328 Drug form; cardiovascular therapy with side effect reduction |
| 09/19/2000 | US6121326 Antiinflammatory agents; antiallergens; analgesics; antiemetics |
| 09/19/2000 | US6121325 Naphthyl compounds promote release of growth hormone |
| 09/19/2000 | US6121322 Antiinflammatory agents |
| 09/19/2000 | US6121321 Substituted methoxy benzylidene indenyl acetic and propionic acids for treating patients with precancerous lesions |
| 09/19/2000 | US6121320 Combination anti-leukemic therapy by utilizing suramin and biologic response modifiers |
| 09/19/2000 | US6121319 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 09/19/2000 | US6121317 Gibberellins (including gibberellins A3 and A7) used in ulcer or wound healing |
| 09/19/2000 | US6121316 2-cyano-3,5-dihydroxyhex-2-enecarboxamide derivatives |
| 09/19/2000 | US6121314 Pharmaceutical composition |
| 09/19/2000 | US6121313 Pharmaceutical composition in a form of self-emulsifying formulation for lipophilic compounds |
| 09/19/2000 | US6121312 Cyclic ether vitamin D3 compounds and uses thereof |
| 09/19/2000 | US6121311 Using a 2-pyrrolidinecarboxyamide compound |
| 09/19/2000 | US6121308 Indole and benzimidazole antithrombotic compounds, such as 1-methyl-2-(n-(4-amidinophenyl)-aminomethyl)-5-(n-(hydroxycarbonylmethyl) -quinoline-8-sulphonylamino)-indole |
| 09/19/2000 | US6121306 Resolving racemic mixture into (1s,4r)- and (1r,4s)-1-azabicyclo(2.2.1)heptan-3-one isomers by formation of di-p-toluoyl hemitartrate salts; storage stable form; use to prepare drugs such as muscarinic agonists |
| 09/19/2000 | US6121305 5,5'-dihydroxy-4,4'-bipyrazole compounds of given formula; free radical scavenger; use to treat cerebral ischemia, heart disease, carcinoma, aging, inflammation or digestive system disease, or in detection of an active oxygen or free radicals |
| 09/19/2000 | US6121304 Pentafluorobenzenesulfonamides and analogs |
| 09/19/2000 | US6121302 Broad spectrum preservative comprising isothiazolones with alkanol-substituted dimethylhydantoin as formaldehyde donor, and an alkyl hydantoin as a stabilizer for isothiazolone; low free formaldehyde, stable in large ph range |
| 09/19/2000 | US6121300 In a topical cosmetic as skin elasticity improver or wrinkle reducer; compounds such as 3-(2-(3-phenyl-5-isoxazolyl)-2-oxoethyl)-thiazolium; adminsistering to treat cataracts, protein aging and diabetes |
| 09/19/2000 | US6121299 Regulating the cytochrome p-450 pathway; inflammation reduced by treating the subject with substances, such as bezafibrate which induce the pathway; inflammation promoted by treating with substances, such as econazole which inhibit the pathway |
| 09/19/2000 | US6121297 Cyanoguanidines as cell proliferation inhibitors |
| 09/19/2000 | US6121295 Treating diabetic complications by administering an insulin sensitivity enhancer such as pioglitazone in combination with a statin compound such as pravastatin |
| 09/19/2000 | US6121294 Reducing the amount of therapeutic agents administered to a diabetic patient by administering an insulin sensitivity enhancer in combination with an alpha-glucosidase inhibitor as said therapeutic agents; side effect reduction |
| 09/19/2000 | US6121293 Benzothiophene compounds, compositions, and methods |
| 09/19/2000 | US6121292 Methods for reversing multidrug resistance |
| 09/19/2000 | US6121291 Paroxetine in the treatment of depression associated with withdrawal from heroin abuse and post-traumatic stress disorder |
| 09/19/2000 | US6121290 Use of GABA uptake inhibitors as anti-tussive agents |
| 09/19/2000 | US6121289 Treating addiction to tobacco by intranasally administering a nicotinic antagonist such as mecamylamine, and carrier |
| 09/19/2000 | US6121288 Visceral fat lowering agent |
| 09/19/2000 | US6121287 Quinoline derivatives |
| 09/19/2000 | US6121284 Specified 1-(alkyl or cycloalkyl)-2-methyl-3-(alkoxycarbonyl)-4-(substituted pyridyl or aryl)-5-oxo-1,4,5,6,7,8-hexahydroquinoline compounds; treating sickle cell anemia, psychoses, depression |
| 09/19/2000 | US6121283 N-substituted-6-(2-(4-trifluoromethylphenyl)phenylcarbonyl-amino) -1,2,3,4-tetrahydroisoquinolines; treating disorders including obesity, hyperlipidemia, and diabetes; microsomal triglyceride transfer protein (mtp); apolipoprotein b (apo-b) |
| 09/19/2000 | US6121282 3-(carboxy, amido, cyano, or hydroxyaminocarbonyl)-6 or 7-substituted-1,2,3,4-tetrahydroisoquinoline compounds |
| 09/19/2000 | US6121281 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use |
| 09/19/2000 | US6121280 Azabicyclic rotomase inhibitors |
| 09/19/2000 | US6121279 Phosphodiesterase inhibitor for treating respiratory system disorders |
| 09/19/2000 | US6121277 Antitumor agents |
| 09/19/2000 | US6121276 Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
| 09/19/2000 | US6121274 Phosphodiesterase inhibitor for treatment of respiratory system disorders |
| 09/19/2000 | US6121273 Isomerase inhibitors effective against neurological disorders, i.e. parkinson's disease, alzheimer's disease, amyotrophic lateral sclerosis; side effect reduction |
| 09/19/2000 | US6121272 Bidentate metalloprotease inhibitors |
| 09/19/2000 | US6121269 Reduction of hair growth |
| 09/19/2000 | US6121267 Substituted piperazines and piperidines as central nervous system agents |
| 09/19/2000 | US6121266 Pyridazines as interleukin-1β converting enzyme inhibitors |
| 09/19/2000 | US6121265 Excitatory amino acid receptor antagonists |
| 09/19/2000 | US6121264 Glutamate receptor antagonist, ampa receptor antagonist, nmda-glycine receptor antagonist, kainic acid neurotoxicity inhibitor, antiischemic agent, psychotropic agent |
| 09/19/2000 | US6121263 Administering synergistic amount of a 1,2,4-benzotriazine-n-oxide derivative prior to administering taxol |
| 09/19/2000 | US6121261 Method for treating attention deficit disorder |
| 09/19/2000 | US6121260 Appetite stimulation with dosage of neuropeptide y (npy) receptor agonist |
| 09/19/2000 | US6121259 Olanzapine-N-oxide compositions and methods |
| 09/19/2000 | US6121258 For treatment of arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease |
| 09/19/2000 | US6121257 Sulfamate containing macrocyclic immunomodulators |
| 09/19/2000 | US6121256 4-(2,3-(2,5-dimethyl-2,5-hexano)dibenzo(b,f)(1,4)thiazepine-11 -yl)benzoic acid or salt |
| 09/19/2000 | US6121254 Dermatological/cosmetic compositions comprising antifungal and antibacterial compounds and reduction of hair loss therewith |
| 09/19/2000 | US6121253 Prostaglandin conjugates for treating or preventing bone disease |
| 09/19/2000 | US6121252 N-acetylated alpha-linked acidic dipeptidase (naaladase) enzyme inhibitors to treat glutamate abnormalities and prostate diseases |
| 09/19/2000 | US6121250 Emulsified liquid agent mainly consisting of water-soluble high-molecular weight compound and electrolyte contains silicone-containing antifoam agent |